Opportunity Information: Apply for RFA 663 11 000002
Apply for RFA 663 11 000002
- The Ethiopia USAID Addis Ababa in the health sector is offering a public funding opportunity titled "USAID/Ethiopia HEAL TB Project" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Nov 26, 2010 and posted on Nov 5, 2010.
- Applicants must submit their applications by Jan 10, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $42,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $42,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The USAID/Ethiopia HEAL TB Project was a discretionary U.S. government grant opportunity, offered through a cooperative agreement, aimed at expanding and improving tuberculosis (TB) prevention, detection, treatment, and program management across Ethiopia. The project was designed to support a comprehensive package of TB interventions, with a strong focus on maintaining high-quality DOTS (Directly Observed Treatment, Short-course) services while also addressing more complex challenges such as multidrug-resistant TB (MDR-TB) and TB/HIV co-infection. In practice, this meant not only supporting clinical and public health activities directly tied to TB care, but also strengthening the broader health system elements that determine whether TB services reach people reliably and safely.
A central part of the opportunity was improving the quality and performance of Ethiopia's TB program through technical assistance to key government structures, specifically the Regional Health Bureaus (RHBs) and Health Zones (HZs). The intent was to strengthen program management and oversight, improve planning and coordination, and help government counterparts implement more effective approaches to both drug-susceptible TB and MDR-TB. Another major component was reinforcing referral linkages between health facilities and the community so that people with TB symptoms could be identified earlier, tested, started on treatment promptly, and supported through completion of therapy. These referral and follow-up systems were especially important for reducing loss to follow-up and improving treatment outcomes.
The grant also emphasized TB/HIV collaboration, reflecting the reality that TB is a leading cause of illness and death among people living with HIV. The project concept therefore included integrated or closely coordinated services, such as stronger screening and referral practices, better collaboration between TB and HIV programs, and improved case management for co-infected patients. Alongside these disease-specific components, the opportunity included substantial Health System Strengthening (HSS) expectations. These HSS activities included supporting District (Woreda) Based Planning to improve local-level prioritization and resource use, instituting infection control measures to reduce TB transmission in health care settings, and improving drug supply management to prevent stock-outs and ensure consistent access to TB medicines. The project also called for implementation of community-based DOTS (CB-DOTS) in both rural and urban areas through Ethiopia's Health Extension Program (HEP), signaling a deliberate push to extend TB services beyond facility walls and into communities where access barriers are often greatest.
From an administrative standpoint, the opportunity was identified as Funding Opportunity Number RFA 663 11 000002 and offered by USAID Ethiopia (Addis Ababa). It anticipated a single award, with an estimated total funding amount and award ceiling of $42,000,000 (with no stated award floor). Cost sharing or matching was required. Eligibility was listed as unrestricted, meaning it was broadly open to many entity types, subject to any additional eligibility clarifications in the full announcement. The opportunity was posted on November 5, 2010, created on November 26, 2010, originally due on December 10, 2010, and later extended to a current closing date of January 10, 2011, with an archive date of February 9, 2011. The CFDA listing associated with it was 98.001 (USAID Foreign Assistance for Programs Overseas). For access issues related to the full announcement, the contact listed was Sam Nagwere, Senior Acquisition and Assistance Specialist, reachable by phone at 251111306027.
FAQs: USAID/Ethiopia HEAL TB Project (RFA 663 11 000002)
What is the USAID/Ethiopia HEAL TB Project grant opportunity?
The USAID/Ethiopia HEAL TB Project was a discretionary U.S. government grant opportunity offered by USAID Ethiopia through a cooperative agreement. It was intended to expand and improve tuberculosis (TB) prevention, detection, treatment, and program management across Ethiopia.
What type of funding instrument was used?
The opportunity was offered through a cooperative agreement.
Who was the funding agency and where was it based?
The funding agency was USAID Ethiopia, based in Addis Ababa.
What was the Funding Opportunity Number (FON)?
The Funding Opportunity Number was RFA 663 11 000002.
How many awards were anticipated?
The opportunity anticipated a single award.
What was the estimated total funding amount and award ceiling?
The estimated total funding amount was $42,000,000, and the award ceiling was also $42,000,000.
Was there an award floor (minimum award amount) stated?
No award floor was stated.
Was cost sharing or matching required?
Yes. Cost sharing or matching was required for this opportunity.
What was the overall purpose of the project?
The project aimed to deliver a comprehensive package of TB interventions across Ethiopia, maintain high-quality DOTS (Directly Observed Treatment, Short-course) services, and address more complex TB challenges such as multidrug-resistant TB (MDR-TB) and TB/HIV co-infection. It also aimed to strengthen health system elements that affect how reliably and safely TB services reach people.
What TB service areas were emphasized?
The opportunity emphasized TB prevention, detection, treatment, and program management. It also highlighted maintaining quality DOTS services while strengthening responses to MDR-TB and TB/HIV co-infection.
What is DOTS, and how was it addressed in this project?
DOTS stands for Directly Observed Treatment, Short-course. The project placed a strong focus on maintaining high-quality DOTS services as part of Ethiopia's broader TB response.
How did the opportunity address multidrug-resistant TB (MDR-TB)?
The project was designed to help government counterparts implement more effective approaches to MDR-TB as part of a broader package of TB interventions and improved program management and oversight.
How did the opportunity address TB/HIV co-infection?
The project emphasized TB/HIV collaboration, including integrated or closely coordinated services. Examples included stronger screening and referral practices, improved collaboration between TB and HIV programs, and better case management for co-infected patients.
Which government structures were key targets for technical assistance?
Technical assistance was intended for key government structures, specifically the Regional Health Bureaus (RHBs) and Health Zones (HZs), to improve the quality and performance of Ethiopia's TB program.
What kinds of program improvements were expected for RHBs and Health Zones?
The opportunity intended to strengthen program management and oversight, improve planning and coordination, and support implementation of more effective approaches for both drug-susceptible TB and MDR-TB.
What role did referral linkages play in the project design?
Reinforcing referral linkages between health facilities and the community was a major component. These systems were meant to help people with TB symptoms get identified earlier, tested, started on treatment promptly, and supported through completion of therapy.
Why was follow-up and referral strengthening important in this opportunity?
The strengthened referral and follow-up systems were described as especially important for reducing loss to follow-up and improving treatment outcomes.
What health system strengthening (HSS) activities were included?
The opportunity included substantial HSS expectations, including support for District (Woreda) Based Planning, infection control measures to reduce TB transmission in health care settings, and improved drug supply management to prevent stock-outs and ensure consistent access to TB medicines.
What is District (Woreda) Based Planning in the context of this opportunity?
District (Woreda) Based Planning was included as part of the HSS expectations, with the purpose of improving local-level prioritization and resource use.
What infection control expectations were described?
The opportunity called for instituting infection control measures intended to reduce TB transmission in health care settings.
What was expected related to TB drug supply management?
The project expected improvements to drug supply management to prevent stock-outs and ensure consistent access to TB medicines.
What is community-based DOTS (CB-DOTS), and where was it to be implemented?
The opportunity called for implementation of community-based DOTS (CB-DOTS) in both rural and urban areas.
How was Ethiopia's Health Extension Program (HEP) involved?
CB-DOTS was to be implemented through Ethiopia's Health Extension Program (HEP), reflecting an intent to extend TB services beyond health facilities and into communities.
Who was eligible to apply?
Eligibility was listed as unrestricted, meaning it was broadly open to many entity types, subject to any additional eligibility clarifications provided in the full announcement.
What was the CFDA number associated with this opportunity?
The CFDA listing associated with this opportunity was 98.001 (USAID Foreign Assistance for Programs Overseas).
When was the opportunity posted and created?
The opportunity was posted on November 5, 2010, and created on November 26, 2010.
What were the application due dates and extension details?
The opportunity was originally due on December 10, 2010, and was later extended to a closing date of January 10, 2011.
When was the archive date?
The archive date was February 9, 2011.
Who was the contact for issues accessing the full announcement?
The listed contact for access issues related to the full announcement was Sam Nagwere, Senior Acquisition and Assistance Specialist.
How could the listed contact be reached by phone?
Sam Nagwere could be reached by phone at 251111306027.
What geographic focus did the project cover?
The project focused on Ethiopia, with activities designed to support TB services across the country and strengthen linkages between communities and health facilities.
Did the opportunity describe support beyond clinical TB services?
Yes. In addition to clinical and public health activities tied directly to TB care, the opportunity included health system strengthening elements like planning, infection control, and drug supply management to help ensure TB services reach people reliably and safely.
Browse more opportunities from the same category: Health
Next opportunity: National Fish Passage Program
Previous opportunity: SNPLMA Round 10 Parks Trails and Natural Areas
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA 663 11 000002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA 663 11 000002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers Program for Research on HIV/AIDS and Mental Health (P30) Apply for PAR 11 019 Funding Number: PAR 11 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Occupational Safety and Health Education and Research Centers (T42) Apply for PAR 10 217 Funding Number: PAR 10 217 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,800,000 |
| Centers of Excellence to Promote a Healthier Workforce (U19) Apply for RFA OH 11 001 Funding Number: RFA OH 11 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,300,000 |
| Exploratory Grant Program in Sudden Unexpected Death in Epilepsy (SUDEP) (P20) Apply for RFA NS 11 006 Funding Number: RFA NS 11 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Infrastructure for Maintaining Primary Care Transformation (IMPaCT) Support for Models of Multi sector, State level Excellence (U18) Apply for RFA HS 11 002 Funding Number: RFA HS 11 002 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Addressing Global TB Prevention And Control In All Populations And Strengthening Health Facilities, Laboratories, Prisons And Other Community Settings Apply for RFA PS 11 002 Funding Number: RFA PS 11 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Patient Safety and Medical Liability Reform Planning Projects (R21) Apply for PAR 11 023 Funding Number: PAR 11 023 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Addressing TB Control And Lung Health Activities Through The Vietnam National Lung Hospital/National TB Program (NLH/NTP) Apply for RFA PS 11 004 Funding Number: RFA PS 11 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Advances in Patient Safety through Simulation Research (R18) Apply for PAR 11 024 Funding Number: PAR 11 024 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Patient Safety and Medical Liability Reform Demonstration Projects (R18) Apply for PAR 11 025 Funding Number: PAR 11 025 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Core Violence and Injury Prevention Program (Core VIPP) Apply for CDC RFA CE11 1101 Funding Number: CDC RFA CE11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Orphans and Vulnerable Children OVC Gender Project in Botswana Apply for 674 11 0002 Funding Number: 674 11 0002 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $16,800,000 |
| The Market for Long Term Care Insurance (R01) Apply for RFA RM 11 002 Funding Number: RFA RM 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrating Comparative Effectiveness Research Findings into Care Delivery through Economic Incentives (R21) Apply for RFA RM 11 001 Funding Number: RFA RM 11 001 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| National Dental Practice Based Research Network Limited Competition (U19) Apply for RFA DE 12 002 Funding Number: RFA DE 12 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Minority HIV/AIDS Research Initiative (MARI) to Build Capacity in Black and Hispanic Communities and Among Black and Hispanic Researchers to Conduct HIV/AIDS Epidemiologic and Prevention Research Apply for RFA PS 11 003 Funding Number: RFA PS 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Translational Research Centers in Thrombotic and Hemostatic Disorders (TRC THD) (U54) Apply for RFA HL 12 008 Funding Number: RFA HL 12 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Behavioral or Social Intervention Planning and Pilot Data Grant (R34) Apply for RFA DE 12 001 Funding Number: RFA DE 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Translational Tools for Clinical Studies of Mind/Body and Manual Therapy CAM Interventions (R01) Apply for RFA AT 11 003 Funding Number: RFA AT 11 003 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R01) Apply for PA 11 033 Funding Number: PA 11 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA 663 11 000002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.